MedPath

Scartrate Cream

Scartrate Cream

Approved
Approval ID

1d666463-8294-5f78-e063-6294a90a91a7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 7, 2025

Manufacturers
FDA

Puretek Corporation

DUNS: 785961046

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dimethicone, Allantoin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59088-326
Product Classification
G
Generic Name
Dimethicone, Allantoin
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 7, 2025
FDA Product Classification

INGREDIENTS (18)

.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
PHENOXYETHANOLInactive
Code: HIE492ZZ3T
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
KUKUI NUT OILInactive
Code: TP11QR7B8R
Classification: IACT
BUTYLENE GLYCOLInactive
Code: 3XUS85K0RA
Classification: IACT
MARINE COLLAGEN, SOLUBLEInactive
Code: 8JC99XGU4W
Classification: IACT
SAFFLOWER OILInactive
Code: 65UEH262IS
Classification: IACT
GLYCERYL 1-STEARATEInactive
Code: 258491E1RZ
Classification: IACT
PEG-100 STEARATEInactive
Code: YD01N1999R
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ALOE VERA LEAFInactive
Code: ZY81Z83H0X
Classification: IACT
DIMETHICONEActive
Quantity: 50 mg in 1 g
Code: 92RU3N3Y1O
Classification: ACTIB
CETYL ALCOHOLInactive
Code: 936JST6JCN
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
DIMETHICONE CROSSPOLYMERInactive
Code: UF7620L1W6
Classification: IACT
ALLANTOINActive
Quantity: 22.5 mg in 1 g
Code: 344S277G0Z
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Scartrate Cream - FDA Drug Approval Details